Non-small-cell lung cancer: how to manage RET-positive disease

Targeted therapy has dramatically changed the history and outcomes of oncogene-addicted non-small-cell lung cancer (NSCLC). RET rearrangements are typically observed in about 1–2% of NSCLC, resulting in constitutive activation of downstream signalling pathways commonly involved in cell growth and su...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrini, Elisa, Mosca, Mirta, Galvani, Linda, Sperandi, Francesca, Ricciuti, Biagio, Metro, Giulio, Lamberti, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281974/
https://www.ncbi.nlm.nih.gov/pubmed/35912003
http://dx.doi.org/10.7573/dic.2022-1-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281974/
https://www.ncbi.nlm.nih.gov/pubmed/35912003
http://dx.doi.org/10.7573/dic.2022-1-5

Ejemplares similares